An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-Administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab(Remicade or CP-P13) in Study CT-P13 3.1
Latest Information Update: 07 Oct 2021
At a glance
- Drugs Infliximab (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Celltrion
- 29 Apr 2016 Results published in the Annals of the Rheumatic Diseases
- 31 Oct 2013 Results were presented at the 2013 American College of Rheumatology (ACR)/Association of Rheumatology Health Professionals (ARHP) Annual Meeting, according to a Hospira media release.
- 30 Oct 2013 Long-term results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.